[144] Life360, Inc. SEC Filing
Rhea-AI Filing Summary
Form 144 filed for Life360, Inc. (LIF) reporting a proposed sale of 17,764 common shares through Fidelity Brokerage Services with an aggregate market value of $1,614,806.22, and an approximate sale date of 09/05/2025 on NASDAQ. The filing states these shares were acquired by restricted stock vesting from the issuer and that payment is compensation. The filing also discloses four prior dispositions by the same seller in the past three months totaling 32,446 shares for gross proceeds of $2,252,183.02. The notice includes the seller's representation that they are not aware of any undisclosed material adverse information.
Positive
- Rule 144 compliance: Seller provided required disclosures including acquisition method, broker, and sale timing.
- Clear acquisition details: Shares were acquired via restricted stock vesting, and payment was recorded as compensation.
Negative
- Insider selling: The filer has executed multiple sales in the past three months totaling 32,446 shares for $2,252,183.02.
- Ongoing dispositions: Proposed sale of 17,764 shares (≈0.023% of outstanding shares) continues insider liquidation of vested shares.
Insights
TL;DR Insider plans to sell recently vested restricted shares worth about $1.6M; recent sales totaled ~32.4k shares for $2.25M.
The Form 144 documents a routine Rule 144 notification for the sale of 17,764 common shares acquired by restricted stock vesting and designated as compensation. The shares are scheduled to be sold through Fidelity on NASDAQ on 09/05/2025 with an aggregate market value of $1,614,806.22. The filing also lists four prior transactions by the same individual across June–August 2025 totaling 32,446 shares and $2,252,183.02 in gross proceeds. Relative to the issuer's stated outstanding shares of 77,548,651, the planned sale represents approximately 0.023% of outstanding shares, indicating the sale is small in absolute ownership terms. The form includes the standard attestation regarding absence of undisclosed material adverse information.
TL;DR This is a compliance disclosure for insider selling of vested compensation; filings and attestations are in place.
The filing shows compliance with Rule 144 procedures: the seller disclosed acquisition details (restricted stock vesting), payment nature (compensation), planned broker, and timing. The notice contains the mandatory representation that the seller is unaware of undisclosed material adverse information. From a governance perspective, repeated sales by an insider are notable for monitoring but the sizes reported here are small relative to total shares outstanding. No information in the filing indicates any corporate governance action, litigation, or other extraordinary event.